p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer
- 1 May 1999
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 51 (2) , 169-174
- https://doi.org/10.1016/s0167-8140(99)00041-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Carcinoma of the rectumDiseases of the Colon & Rectum, 1996
- Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomasEuropean Journal Of Cancer, 1996
- p53 Immunohistochemical and Genetic Alterations are Associated at High Incidence with Post-Irradiated Locally Persistent Prostate CarcinomaJournal of Urology, 1996
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- Outcome in colorectal adenocarcinoma: two seven-year studies of a population.BMJ, 1993
- p53, guardian of the genomeNature, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCERThe Lancet, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958